Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hongqian Zhu"'
Autor:
Yaqin Jiang, Shishan Xiao, Shengwen Huang, Xuemei Zhao, Siruiyun Ding, Qianqian Huang, Wei Xiao, Zhe Li, Hongqian Zhu
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Background Imatinib (IM) is the primary treatment for patients with chronic-phase CML (CML-CP). However, an increasing number of CML-CP patients have developed resistance to IM. Our study aims to explore the expression of miR-629-5p in extracellular
Externí odkaz:
https://doaj.org/article/695826b22e0b47369f714ae02eb1197c
Autor:
Yunfan Yang, Yuntao Liu, Hui Sun, Li Meng, Hai Lin, Chunyan Chen, Jianda Hu, Xuliang Shen, Minghui Duan, Yanli Zhang, Dilinazi Abulaiti, Jinghua Wang, Hongqian Zhu, Luoming Hua, Qing Leng, Chun Zhang, Lili Sun, Weiming Li, Huanling Zhu, Bingcheng Liu, Jianxiang Wang
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
To evaluate the efficacy and safety of flumatinib in the later-line treatment of Chinese patients with Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia (CP-CML previously treated with tyrosine kinase inhibitors (TKIs). Patients
Externí odkaz:
https://doaj.org/article/753d35b5f240403c94caeb3d09ec890b
Autor:
Hong Chen, Yan Wen, Yun Zeng, Lie Lin, Bihong Sun, Hongqian Zhu, Huiqing He, Xiaotao Wang, Waiyi Zou, Caifeng Zheng, Liling Zheng, Jinxiong Huang, Liping Pang, Jixian Huang, Yuming Zhang, Haiqing Lin, Zelin Liu, Wanshou Zhu, Qiang Wang, Xuan Zhou, Xiaoli Liu, Hong Qu, Zhenfang Liu, Xin Du, Na Xu
Publikováno v:
Oncology and Therapy, Vol 12, Iss 1, Pp 131-145 (2023)
Abstract Introduction Chronic myeloid leukemia (CML) is a chronic disease with treatment-free remission (TFR) increasingly regarded as a feasible goal of treatment. However, various factors may influence adherence to international guidelines for CML
Externí odkaz:
https://doaj.org/article/1a4339b229f24421b410fec79bd53d69
Publikováno v:
Advances in Mechanical Engineering, Vol 10 (2018)
Based on the magnetic field modulation effect, this article presents a magnetic gear with intersecting axes and straight stationary pole-pieces. Except for a higher utilization of permanent magnets and a greater output torque, the magnetic gear with
Externí odkaz:
https://doaj.org/article/0a40881ca0be4ad5aba66302ca6eb3f8
Publikováno v:
Highlights in Business, Economics and Management. 4:90-95
The theme of this research is the reasons and trends for declining the ratings of the NBA all-star game. This paper included research on the NBA All-Star Game. This paper also put forward some methods to solve the reasons for the decline in ratings.
Autor:
Hong Chen, Yan Wen, Yun Zeng, LiE Lin, Xin Du, Zhenfang Liu, Bihong Sun, Hongqian Zhu, Huiqing He, Xiaotao Wang, Waiyi Zou, Caifeng Zheng, Liling Zheng, Jinxiong Huang, Liping Pang, Jixian Huang, Yuming Zhang, Haiqing Lin, Zelin Liu, Wanshou Zhu, Xuan Zhou, Qiang Wang, Xiaoli Liu, Qifa Liu, Na Xu
Publikováno v:
Blood. 140:10841-10842
Publikováno v:
Bioscience Reports
Alterations in messenger RNAs (mRNAs) of protein-coding genes can influence the malignant behaviors of acute lymphoblastic leukemia (ALL) cells. According to the prediction from The Cancer Genome Atlas (TCGA) database, we discovered that glutathione
Autor:
Hongqian Zhu, Shishan Xiao
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Leukemia cells have strong proliferation and anti-apoptosis capabilities. The purpose of this study was to investigate the effect of silencing the leucine-rich alpha-2-glycoprotein1 (LRG1) gene, which was found to regulate tumor proliferat
Publikováno v:
Bioscience Reports; Oct2020, Vol. 40 Issue 10, p1-11, 11p
Autor:
Hongsheng Zhou, Jixian Huang, Lin Li, Ziyuan Lu, Zhiping Fan, Fen Huang, Huan Li, Hongqian Zhu, Xuan Li, Song Zhang, Zhi Liu, Rui Cao, Yuling Li, Xiaoli Liu, Qifa Liu, Na Xu, Xuan Zhou
Publikováno v:
Journal of Hematology & Oncology
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-8 (2016)
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-8 (2016)
Background Frequency relapses are common in Philadelphia chromosome-positive (Ph-positive) acute lymphoblastic leukemia (ALL) following tyrosine kinase inhibitors (TKIs). CDKN2A/B is believed to contribute to this chemotherapy resistance. Methods To